Related Experiment Video
Updated: May 10, 2026

An In Vitro System to Study Tumor Dormancy and the Switch to Metastatic Growth
Published on: August 11, 2011
A wake-up call for hibernating tumour cells
Disseminated tumour cells (DTCs) remain dormant until specific blood vessel signals cause them to reactivate. Mature vessels maintain dormancy, while sprouting vessels trigger DTCs to emerge, leading to cancer relapse.
Area of Science:
- Oncology
- Vascular Biology
- Cancer Metastasis
Background:
- Disseminated tumour cells (DTCs) can enter long-term dormancy, a state crucial for understanding cancer recurrence.
- The mechanisms governing DTC emergence from quiescence and subsequent metastatic relapse are not fully understood.
Discussion:
- Microvascular niches play a critical role in regulating DTC dormancy and reactivation.
- Mature blood vessels secrete factors that maintain DTC quiescence.
- Sprouting microvasculature provides signals that stimulate DTCs to exit dormancy.
Key Insights:
- Distinct microvascular environments differentially regulate DTC fate.
- The transition from dormancy to active proliferation is influenced by the surrounding vasculature.
- Understanding these niche-specific signals is key to preventing metastatic relapse.
Outlook:
- Targeting specific microvascular signals could offer novel therapeutic strategies to maintain DTC dormancy.
- Further research into the molecular crosstalk between DTCs and the microvasculature is warranted.
- Developing methods to inhibit reactivation signals from sprouting vessels may prevent cancer recurrence.
More Related Videos
08:48An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation
Published on: June 30, 2015
12:48A Time-lapse, Label-free, Quantitative Phase Imaging Study of Dormant and Active Human Cancer Cells
Published on: February 16, 2018
Related Concept Videos
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Tumor Immunotherapy
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...